YD Bio Limited balance sheet YDESW

Annual Quarterly

As of Dec 31, 2025, YD Bio Limited had total assets of $13.8 million and total liabilities of $16.6 million. Stockholders' equity was negative, at -$2.9 million, because liabilities exceed assets. It held $6.0 million in cash and investments against $13,528 of total debt, net cash of $6.0 million. The current ratio, current assets divided by current liabilities, was 5.88.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2025
Dec 31, 2025
Assets
Cash
6
Cash and investments
6
Receivables
0
Inventory
2
Total current assets
10
Property and equipment, net
0
Total assets
14
Liabilities and equity
Accounts payable
0
Total current liabilities
2
Total liabilities
17
Stockholders' equity
-3
Debt
Debt due within a year
0
Lease liabilities
0
Total debt
0
Net cash
6
Ratios
Current ratio
5.88x
Return on assets
-60.32%
Book value per share
-0.04
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
YDES (Nasdaq), YDESW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Taipei City
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2011674
Former names
True Velocity, Inc./DE (until Jun 21, 2024)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.